Our News
CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research
Our News
CQDM Congratulates Perceiv AI, DalCor Pharmaceuticals, and Dr. Tardif for Winning the 2024 ADRIQ RSRI Innovation Award
Our News
CQDM present at NeuroSphere
Our News
New hire Jeanne Ouellet-Ayotte, Marketing & Communication Coordinator
Our News
New hire Xavier Linker, new Director of Strategic Initiatives
Our News
CQDM and YCharOS Inc. fund the development of an antibody characterization platform to facilitate R&D and propel the development of new drugs
Our News
CQDM, Brain Canada and industry partners join forces to address unmet medical needs in the treatment of brain disorders
Our News
CQDM and Epitopea Fund the Development and Validation of CryptoMapTM a Supportive Platform Enabling the Development of RNA-based Immunotherapies
Our News
GlycoNet and CQDM collaborate to boost drug discovery and develop new health solutions for Canadians